// App-Quantinova.ai

3836 : Novel conditionally active biologic anti-Axl antibody-drug conjugate demonstrates anti-tumor efficacy and improved safety profile

Researchers

Presenter

  • Cathy Chang

Principal Investigators

  • Gerhard Frey

  • William J. Boyle

  • Leslie L. Sharp

  • Jay M. Short

Medical Centers

  • BioAtla, San Diego, CA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • Hepatocyte growth factor receptor

  • Stromal interaction molecule 1

  • Apparent diffusion coefficient

Drug/Treatment

  • L-Tyrosine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved